[go: up one dir, main page]

MX2016013826A - Formulaciones de peroxido y metodos y aplicaciones para utilizarlas. - Google Patents

Formulaciones de peroxido y metodos y aplicaciones para utilizarlas.

Info

Publication number
MX2016013826A
MX2016013826A MX2016013826A MX2016013826A MX2016013826A MX 2016013826 A MX2016013826 A MX 2016013826A MX 2016013826 A MX2016013826 A MX 2016013826A MX 2016013826 A MX2016013826 A MX 2016013826A MX 2016013826 A MX2016013826 A MX 2016013826A
Authority
MX
Mexico
Prior art keywords
compositions
applicators
methods
same
peroxide formulations
Prior art date
Application number
MX2016013826A
Other languages
English (en)
Other versions
MX381290B (es
Inventor
D Shanler Stuart
Powala Christopher
Beger Brian
Tiong Lim Sian
Phillips Christopher
Rodney Greenaway Evans Charles
A Botta Michael
Nagler Thomas
Barry Brown Marc
Original Assignee
Aclaris Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aclaris Therapeutics Inc filed Critical Aclaris Therapeutics Inc
Publication of MX2016013826A publication Critical patent/MX2016013826A/es
Publication of MX381290B publication Critical patent/MX381290B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/22—Peroxides; Oxygen; Ozone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M35/00—Devices for applying media, e.g. remedies, on the human body
    • A61M35/003—Portable hand-held applicators having means for dispensing or spreading integral media
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/87—Application Devices; Containers; Packaging
    • A61K2800/872—Pencils; Crayons; Felt-tip pens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/75—General characteristics of the apparatus with filters
    • A61M2205/7545—General characteristics of the apparatus with filters for solid matter, e.g. microaggregates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

Las modalidades hacen referencia a una composición estable que comprende 2-propanol y peróxido de hidrógeno, y aplicadores configurados para almacenar, dispensar y aplicar dichas composiciones estables. Tales composiciones pueden ser utilizadas para tratar afecciones de la piel, tales como verrugas, condiloma acuminado, molusco contagioso, acrocordón, queratosis seborreica o una combinación de estas. Dichas modalidades también describen composiciones que se administran en el hogar, composiciones que se administran en consultorio, composiciones de venta libre y kits para el uso de dichas composiciones.
MX2016013826A 2014-04-21 2015-04-21 Formulaciones de peróxido y métodos y aplicaciones para utilizarlas. MX381290B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461982217P 2014-04-21 2014-04-21
US201462085466P 2014-11-28 2014-11-28
PCT/US2015/026948 WO2015164427A1 (en) 2014-04-21 2015-04-21 Peroxide formulations and methods and applicators for using the same

Publications (2)

Publication Number Publication Date
MX2016013826A true MX2016013826A (es) 2017-07-28
MX381290B MX381290B (es) 2025-03-12

Family

ID=54333109

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016013826A MX381290B (es) 2014-04-21 2015-04-21 Formulaciones de peróxido y métodos y aplicaciones para utilizarlas.

Country Status (17)

Country Link
US (7) US9675639B2 (es)
EP (1) EP3134061B1 (es)
JP (1) JP6622217B2 (es)
KR (1) KR20170029413A (es)
CN (1) CN106659643B (es)
AU (1) AU2015249841B2 (es)
BR (1) BR112016024630B1 (es)
CA (1) CA2946568C (es)
DK (1) DK3134061T3 (es)
ES (1) ES2828711T3 (es)
IL (1) IL248462B (es)
MX (1) MX381290B (es)
PL (1) PL3134061T3 (es)
PT (1) PT3134061T (es)
RU (1) RU2711662C2 (es)
SG (1) SG11201608775XA (es)
WO (1) WO2015164427A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3134061B1 (en) 2014-04-21 2020-10-07 Aclaris Therapeutics, Inc. Peroxide formulations and methods and applicators for using the same
WO2016142305A1 (en) * 2015-03-06 2016-09-15 Medical Brands Research B.V. Applicator
KR102243420B1 (ko) * 2016-03-31 2021-04-21 가부시키가이샤 지씨 용기 포함 시린지
EP3228273B1 (en) * 2016-04-06 2019-12-25 Clinica de Ortodoncia y Cirugia Maxilofacial, S.L. Surgical marker
RU2019107362A (ru) * 2016-08-17 2020-09-22 Акларис Терапьютикс, Инк. Способы и композиции для лечения бородавок
CN111278414A (zh) 2017-06-06 2020-06-12 维里卡制药有限公司 皮肤病的治疗
USD900312S1 (en) 2017-06-15 2020-10-27 Verrica Pharmaceuticals, Inc. Applicator
CN110997054B (zh) * 2017-06-15 2024-10-25 维里卡制药有限公司 用于治疗身体表面病症的装置和方法
KR102658959B1 (ko) 2017-06-30 2024-04-22 리제너론 파아마슈티컬스, 인크. 안티 롤 피쳐를 갖는 자동 주입기
WO2019070980A2 (en) 2017-10-04 2019-04-11 Verrica Pharmaceuticals, Inc. SYNTHESIS OF CANTHARIDINE
US20200215107A1 (en) * 2019-01-03 2020-07-09 L'oreal Catalytic systems including a peroxide for delivery of oxygen to skin and related methods of use
SI25540A (sl) 2019-01-14 2019-05-31 Tompa Majcen Dominika Formulacije s spojinami aktivnega kisika in pripomočki za njihovo aplikacijo
US20210128218A1 (en) * 2019-10-30 2021-05-06 Scapa Tapes North America Llc Skin lesion treatment device
WO2021116651A1 (en) * 2019-12-09 2021-06-17 Futura Medical Developments Limited Topical composition and methods of measuring the cooling abaility of a topical composition
CN110898076A (zh) * 2019-12-12 2020-03-24 刘贤贤 一种去除角质的药物及其制备方法
US11672880B2 (en) * 2020-04-20 2023-06-13 Honeywell Federal Manufacturing & Technologies, Llc Methods and devices for sterilizing medical equipment
CN112586864A (zh) * 2020-12-25 2021-04-02 朱燕妮 一种消毒刷
WO2024006550A1 (en) 2022-07-01 2024-01-04 Jjr&D, Llc Method of preventing and treating chemotherapy-induced alopecia
WO2024191921A1 (en) * 2023-03-10 2024-09-19 R2 Technologies, Inc. Cryo methods and systems for medical treatments

Family Cites Families (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US825883A (en) 1905-07-10 1906-07-10 Walter Heinrici Stable solution of peroxid of hydrogen.
US825833A (en) 1905-08-31 1906-07-10 Robert L Hight Electric clock.
US1139774A (en) 1909-04-20 1915-05-18 Knox Thenardine Chemical Company Antiseptic compound.
US3995631A (en) 1971-01-13 1976-12-07 Alza Corporation Osmotic dispenser with means for dispensing active agent responsive to osmotic gradient
US3949072A (en) 1971-03-11 1976-04-06 Tenta Louis T Topical composition for treatment of seborrheic keratosis
US3954974A (en) 1972-06-09 1976-05-04 Paul Herzog Disinfectant for the surface of human body parts containing hydrogen peroxide
US4018802A (en) 1975-04-09 1977-04-19 Merck & Co., Inc. 9-Thia- and oxothia- and 9-dioxothia-11,12-seco-prostaglandins and processes
US4363815A (en) 1975-07-23 1982-12-14 Yu Ruey J Alpha hydroxyacids, alpha ketoacids and their use in treating skin conditions
US4128564A (en) 1976-03-22 1978-12-05 Merck & Co., Inc. 9-Thia- and oxothia- and 9-dioxothia-11,12-seco-prostaglandins
US4112121A (en) 1976-07-12 1978-09-05 Tenta Louis T Method and composition for the treatment of seborrheic keratosis
GB2068225B (en) * 1980-06-09 1983-12-14 Quinodern Ltd Dermatological compositions containing hydrogen peroxide
US4485091A (en) 1980-07-15 1984-11-27 Quinoderm Limited Dermatological compositions
US4588590A (en) 1981-12-21 1986-05-13 Jaye-Boern Laboratories, Inc. Method of treating keratosis and compositions useful therefor
US4428933A (en) * 1982-08-02 1984-01-31 King John R Composition for treating acne, method of manufacturing said composition, and method of treating skin
US4438102A (en) 1982-08-10 1984-03-20 Ciro's Touch, Ltd. Method of promoting tissue growth
US4518583A (en) 1983-02-22 1985-05-21 Gallina Damian J Hemorrhoid and anorectal disease treatment method
LU85789A1 (fr) 1985-02-26 1986-09-02 Oreal Utilisation dans les domaines therapeutique et cosmetique d'une solution anhydre de peroxyde d'hydrogene
US5348556A (en) * 1988-06-14 1994-09-20 Basf Corporation Volatile carpet sanitizing shampoo containing hydrogen peroxide
AU3687489A (en) 1988-07-22 1990-02-19 Ciro's Touch, Ltd. Compositions and methods for treating skin conditions and promoting wound healing
US5380764A (en) 1989-06-08 1995-01-10 Herzog; Paul Composition of vitamin A, glucose and hydrogen peroxide for cosmetic or pharmaceutical use
US5200170A (en) 1989-07-18 1993-04-06 Mcdow Ronald A Medical process--use of dichlorodifluoromethane (CCl2 F2) and chlorodifluoromethane (CHClF2) as cryogens for treating skin lesions
GB9007762D0 (en) 1990-04-05 1990-06-06 Beecham Group Plc Novel compounds
JPH04159229A (ja) * 1990-09-14 1992-06-02 Senju Pharmaceut Co Ltd 真珠腫治療剤
JP3274706B2 (ja) 1992-06-18 2002-04-15 三井化学株式会社 耐熱防振ゴム用ゴム組成物
JPH06206825A (ja) 1992-12-11 1994-07-26 Nippon Rooshiyon Kk 白癬菌、湿疹等による皮膚病の治療剤及び 皮膚殺菌活性化剤
US5415994A (en) 1993-08-02 1995-05-16 Quidel Corporation Lateral flow medical diagnostic assay device with sample extraction means
JPH07165553A (ja) 1993-12-07 1995-06-27 Kobe Steel Ltd メラニン原因症予防治療剤
GB2285218A (en) 1993-12-17 1995-07-05 William Elwyn Roberts An aid to recovery from disease caused by bacteria fungi viruses and malignant cells
US5476664A (en) 1994-04-15 1995-12-19 Leonard Bloom Treatment of warts using anthralins and occlusion
US5594015A (en) 1994-06-22 1997-01-14 Regents Of The University Of California Thiazolidine derivatives for the treatment of psoriasis
DE19640364A1 (de) 1996-09-30 1998-04-02 Basf Ag Topische Mittel zur Prophylaxe oder Behandlung bakterieller Hautinfektionen
US5958984A (en) 1996-10-10 1999-09-28 Devillez; Richard L. Method and composition for skin treatment
US5736582A (en) 1996-10-10 1998-04-07 Devillez; Richard L. Method and composition for controlled delivery of nascent oxygen from hydrogen peroxide source for skin treatment
US6028104A (en) 1997-01-30 2000-02-22 Ecolab Inc. Use of peroxygen compounds in the control of hairy wart disease
US5780064A (en) 1997-09-12 1998-07-14 Babson Bros. Co. Germicidal compositions for the treatment of animal infectious diseases of the hoof
US6723890B2 (en) * 1998-06-30 2004-04-20 Sandia Corporation Concentrated formulations and methods for neutralizing chemical and biological toxants
US6071541A (en) 1998-07-31 2000-06-06 Murad; Howard Pharmaceutical compositions and methods for managing skin conditions
US6146640A (en) 1998-08-31 2000-11-14 Dyke; John Paul Immune system catalyst
US5916568A (en) * 1998-11-09 1999-06-29 Smyth; Teresa A. Flash-dry disinfectant solution for use as a hand wash
US6283933B1 (en) * 1998-12-23 2001-09-04 Closure Medical Corporation Applicator for dispensable liquids
US6245957B1 (en) 1999-09-02 2001-06-12 The United States Of America As Represented By The Secretary Of The Army Universal decontaminating solution for chemical warfare agents
US20020031556A1 (en) 2000-07-21 2002-03-14 Lindahl Ake R. Stabilized hydrogen peroxide composition and method of making a stabilized hydrogen peroxide composition
WO2002064151A1 (en) 2001-02-09 2002-08-22 Physician's Choice Of Arizona, Inc. Acrochordon alleviation
US7381427B2 (en) 2001-02-09 2008-06-03 Mickey Miller Seborrheic keratosis treatment
US6849082B2 (en) * 2001-10-19 2005-02-01 Spartan Products Inc. Method for curing cyanoacrylate adhesives
GB0206793D0 (en) * 2002-03-22 2002-05-01 Galactogen Products Ltd Alertness bar
EP1393629A1 (en) * 2002-08-29 2004-03-03 Tevan B.V. Aqueous disinfecting compositions based on quaternary ammonium monomers
US20040101571A1 (en) * 2002-09-11 2004-05-27 Pamela Reed Use of hydrogen peroxide for the treatment of warts
US20080206161A1 (en) 2002-10-25 2008-08-28 Dov Tamarkin Quiescent foamable compositions, steroids, kits and uses thereof
US20070111954A1 (en) * 2003-07-23 2007-05-17 Cuticeuticals, Inc. Apparatus and method of wart treatment
US8257780B2 (en) 2003-10-31 2012-09-04 Resource Development L.L.C. Therapeutic composition containing an organosilane quaternary compound and hydrogen peroxide for treating skin disorders and methods of using
US8197797B2 (en) * 2004-04-12 2012-06-12 Mineral Science Co. Compositions for oral hygiene and method for using same
ES2683330T3 (es) 2004-05-14 2018-09-26 Virox Technologies Inc. Desinfectante de la piel basado en peróxido de hidrógeno
US20050266081A1 (en) * 2004-05-26 2005-12-01 Rogozinski Wallace J Antimicrobial silver hydrogels
US7511007B2 (en) * 2005-02-25 2009-03-31 Solutions Biomed, Llc Aqueous sanitizers, disinfectants, and/or sterilants with low peroxygen content
WO2006093792A1 (en) * 2005-02-25 2006-09-08 Solutions Biomed, Llc Aqueous disinfectants and sterilants
JP2007008874A (ja) * 2005-06-30 2007-01-18 Gc Corp ペースト状の歯科用漂白材
WO2008024422A2 (en) * 2006-08-24 2008-02-28 Solutions Biomed, Llc Methods and compositions for decontamination and treatment of disease or injury
US8518076B2 (en) * 2007-01-08 2013-08-27 Advanced Medical Solutions (Plymouth) Limited Surgical adhesive applicator
US8273385B1 (en) * 2008-10-17 2012-09-25 Thres Flo, LLC Oral rinse composition and method
US8258830B2 (en) 2009-01-20 2012-09-04 Mediatek Inc. Methods for calibrating gated oscillator and oscillator circuit utilizing the same
GB2467349A (en) * 2009-01-30 2010-08-04 Alexander James Hanbury Duggan Pre-treatment thermal transmission agent for wart or corn
US9744150B2 (en) * 2009-10-21 2017-08-29 Dow Pharmaceutical Sciences Inc. Suspension containing micronized benzoyl peroxide
WO2011080080A1 (en) 2009-12-15 2011-07-07 Universitetet I Oslo COMPOSITION COMPRISING NANOPARTICLES OF TiO2
RU2426823C1 (ru) * 2010-03-09 2011-08-20 Федеральное государственное образовательное учреждение высшего профессионального образования "Пермская государственная сельскохозяйственная академия имени академика Д.Н. Прянишникова" Электролит для микродугового оксидирования алюминия и его сплавов
US9241921B2 (en) * 2011-05-02 2016-01-26 Pankaj Modi Photosensitizer composition for treating skin disorders
US9486829B2 (en) * 2011-06-04 2016-11-08 Optmed, Inc. Applicator
KR20130002696A (ko) 2011-06-29 2013-01-08 (주)제이브이엠 불량약품 검사장치
US20140030314A1 (en) * 2012-01-13 2014-01-30 Brian G. Larson Treatment of skin disease
EP3134061B1 (en) 2014-04-21 2020-10-07 Aclaris Therapeutics, Inc. Peroxide formulations and methods and applicators for using the same
RU2019107362A (ru) 2016-08-17 2020-09-22 Акларис Терапьютикс, Инк. Способы и композиции для лечения бородавок

Also Published As

Publication number Publication date
KR20170029413A (ko) 2017-03-15
JP2017513907A (ja) 2017-06-01
RU2016145236A (ru) 2018-05-22
US10098910B2 (en) 2018-10-16
PT3134061T (pt) 2020-11-04
EP3134061A1 (en) 2017-03-01
RU2016145236A3 (es) 2018-08-29
CN106659643A (zh) 2017-05-10
US10729720B2 (en) 2020-08-04
RU2711662C2 (ru) 2020-01-20
US20190046565A1 (en) 2019-02-14
US20180110805A9 (en) 2018-04-26
AU2015249841A1 (en) 2016-12-15
CA2946568A1 (en) 2015-10-29
EP3134061B1 (en) 2020-10-07
SG11201608775XA (en) 2016-11-29
US20150328259A1 (en) 2015-11-19
IL248462B (en) 2020-11-30
IL248462A0 (en) 2016-12-29
MX381290B (es) 2025-03-12
CN106659643B (zh) 2020-06-19
ES2828711T3 (es) 2021-05-27
BR112016024630A2 (pt) 2017-08-15
US20180000863A1 (en) 2018-01-04
DK3134061T3 (da) 2020-10-26
BR112016024630B1 (pt) 2021-02-17
US9675639B2 (en) 2017-06-13
US9980983B2 (en) 2018-05-29
PL3134061T3 (pl) 2021-02-22
US20180303875A1 (en) 2018-10-25
US10493103B2 (en) 2019-12-03
US20210137974A1 (en) 2021-05-13
JP6622217B2 (ja) 2019-12-18
US20180185413A1 (en) 2018-07-05
US10653721B2 (en) 2020-05-19
CA2946568C (en) 2020-07-07
US20180008636A1 (en) 2018-01-11
WO2015164427A1 (en) 2015-10-29
EP3134061A4 (en) 2018-01-03
AU2015249841B2 (en) 2020-05-14

Similar Documents

Publication Publication Date Title
MX2016013826A (es) Formulaciones de peroxido y metodos y aplicaciones para utilizarlas.
MX389228B (es) Composiciones para tratar el cabello.
MX365294B (es) Inhibidores de proteína cinasa dependiente de adn.
MX2015011898A (es) Compuestos de pirazolo y usos de los mismos.
MX2017013562A (es) Reguladores de microbioma y usos relacionados de los mismos.
CL2015002675A1 (es) Composiciones de arnm de cftr y métodos y usos relacionados
MX2017004896A (es) Uso de hexadeca-8, 15-dienal como producto quimico aromatico.
MX370903B (es) Composiciones de ácido percarboxílico estables y sus usos.
MX2015012334A (es) Metodos y composiciones para el control de malezas.
HK1213888A1 (zh) 治療化合物和組合物以及其作為pkm2調節劑的用途
MX343071B (es) Metodos y composiciones para el control de malezas.
MX2016011898A (es) Composiciones de compuestos selenoorganicos y metodos de uso de los mismos.
WO2014186704A3 (en) Novel compounds for the treatment of cystic fibrosis
ECSP13012573A (es) 6-amino-nicotinamidas sustituidas como moduladores de KCNQ2/3
EP4414376A3 (en) Novel depsipeptide and uses thereof
WO2018143552A3 (ko) 탈모방지 또는 발모촉진용 주사용 조성물
MX381544B (es) Composición de células estromales mesenquimatosas para usare en el tratamiento de la sepsis en un sujeto.
PH12015502405A1 (en) Methods and compositions for wound healing
AU2015279834A8 (en) Use of peptides that block metadherin-SND1 interaction as treatment for cancer
ECSP13012453A (es) 2-oxi-quinolina-3-carboxamidas sustituidas como moduladores KCNQ2/3
MX2015016410A (es) Esteres de acidos oligo-hidroxicarboxilicos y uso de los mismos.
EA201071369A1 (ru) Композиции для лечения выпадения волос
AU2015267160A8 (en) Methods and compositions for preventing ischemia reperfusion injury in organs
MX368268B (es) Formulacion de atazanavir y cobicistat para el tratamiento del virus de inmunodeficiencia humana (vih).
MX2019001838A (es) Metodos y composiciones para el tratamiento de verrugas.